NMRD

Nemaura Medical Inc. NMRD

NMRD
Nemaura Medical Inc. VIVE
Viveve Medical, Inc. VICA
Rafina Innovations Inc. TNGNQ
Tengion, Inc. UPH
UpHealth, Inc. KLDO
Kaleido Biosciences, Inc. CYPS
Cyclo3pss Corporation LCDX
Caliber Imaging & Diagnostics, Inc. REMI
Remedent, Inc. NWCI
NewCardio, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NMRD VIVE VICA TNGNQ UPH KLDO CYPS LCDX REMI NWCI
6M 0.00 % 0.00 % 600.00 % 900.00 % -81.93 % 0.00 % -50.00 % 500.00 % -94.00 % 0.00 %
YTD 0.00 % -50.00 % 600.00 % 900.00 % 25.65 % 0.00 % -50.00 % 500.00 % -99.00 % 900.00 %
1Y -50.00 % -50.00 % 600.00 % 900.00 % -87.29 % 0.00 % -50.00 % 500.00 % -99.00 % 900.00 %
3Y -99.99 % -100.00 % -58.82 % 9 900.00 % -99.72 % -90.91 % -98.00 % 0.00 % -99.65 % 0.00 %
5Y -100.00 % -100.00 % -98.97 % 9 900.00 % -99.69 % -100.00 % -99.68 % -99.88 % -99.70 % -95.00 %
10Y -100.00 % -100.00 % -99.35 % 9 900.00 % -99.69 % -100.00 % -98.00 % -99.94 % -99.65 % -66.67 %
From the beginning -100.00 % -100.00 % -99.76 % 9 900.00 % -99.69 % -100.00 % -99.09 % -99.87 % -99.98 % -99.99 %

Dividend